Trial Profile
A retrospective study of non-TNF therapy (Tocilizumab and Abatacept) with tapering/stopping of methotrexate in patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 30 Aug 2016 New trial record